RxSight

Forecast & Rating9 analysts currently cover RxSight, with about 11.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $8.43, about 62.4% upside from the current price of $5.19. Price targets range from $6.50 to $11.00 — a wide spread, showing clear disagreement over just how much RxSight can rise. Historically, about 72.7% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on RxSight's outlook. Data as of Jul 15, 2026; for reference only and not investment advice.